ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±²Ìε¡¢¡¢ºúÃÎÑÕ£©¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐÄÉñ¾ÄÚ¿ÆÂ½ÕýÆëÍŶÓÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯Autophagy£¨IF13.391£©½ÒÏþÁËÌâΪ¡°FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation¡±µÄ×îÐÂÔ´´ÐÔÑо¿¡£Ñо¿·¢Ã÷£¬£¬£¬FOXP3+¾ÞÊÉϸ°û¿ÉÒÔÒÖÖÆ¼±ÐÔȱѪÐÔÄÔ×äÖÐÓÕµ¼µÄÉñ¾Ñ×Ö¢¡£
¼±ÐÔȱѪÐÔÄÔ×äÖÐ(Acute ischemic stroke, AIS)ÊÇÒ»Ö־߱¸¸ßÖ²ÐÓë¸ßÖÂËÀÂʵÄÑÏÖØ¼²²¡£¬£¬£¬²¢ÇÒÔÚÌìϹæÄ£ÄÚÆÕ±éÂþÑÜ¡£¸Ã¼²²¡µÄ²¡ÀíÀú³Ì¿É¸ÅÀ¨Îª£¬£¬£¬ÄÔѪÁ÷µÄͻȻÖÐÖ¹²¢µ¼ÖÂÉñ¾ÔªéæÃü£¬£¬£¬ÆäÒýÆðµÄÑ×Ö¢»á½øÒ»²½¼Ó¾çȱѪ°ë°µ´ø²¡±ä¹æÄ£µÄÀ©´ó£¬£¬£¬¼ÓÖØ»¼ÕߵIJ¡Çé¡£Òò´Ë£¬£¬£¬ÓÐÒ»ÖÖÁÙ´²¿´·¨ÒÔΪ£¬£¬£¬Í¨¹ýÊÊʱÓÐÓõØÒÖÖÆÄÔ×äÖкóÉñ¾Ñ×Ö¢£¬£¬£¬Îª×éÖ¯ÐÞ¸´ºÍÔÙÉúÌṩÓÐÀûµÄÇéÐΣ¬£¬£¬¾ß±¸ÓÐʵ¼ùÒâÒåµÄÁÙ´²¼ÛÖµ¡£
ÔÚ΢¹Û²ãÃæ£¬£¬£¬¾ÞÊÉϸ°ûÔÚAISÏà¹Ø²¡ÀíÐÄÀíÀú³ÌÖÐʩչ×ÅÒªº¦×÷Ó㬣¬£¬Æä×÷Ϊ¿ìËÙ·´Ó³µÄÃâÒßϸ°û´ó×Ú½þÈóÄÔ×äÖв¡Ôͬʱ£¬£¬£¬ÔÚAISÖУ¬£¬£¬¸Ãϸ°û¿Éͨ¹ý°ûÔá×÷ÓÃ(effercytosis)À´É¨³ýËðÉ˵Äϸ°û»òË鯬£¬£¬£¬ÖÕֹϸ°ûéæÃüÒýÆðµÄÉñ¾Ñ×Ö¢£¬£¬£¬´Ó¶øÔö½øÄÚÎÈ̬µÄ»Ö¸´¡£È»¶ø£¬£¬£¬Í¨¹ý¸Ä±ä¾ÞÊÉϸ°ûµÄ¹¦Ð§ÊôÐÔÀ´ÒÖÖÆÄÔ×äÖкóÉñ¾Ñ×Ö¢µÄ·Ö×ÓÉúÎïѧ»úÖÆÉв»Ã÷È·¡£ÖµµÃ×¢ÖØµÄÊÇ£¬£¬£¬FOXP3Êǵ÷ÀíÐÔTϸ°û(regulatory T cell, Treg)µÄÖ÷ÒªÃâÒßÒÖÖÆ×ªÂ¼Òò×Ó¡£åÇÀ´£¬£¬£¬ÓÐÔ½À´Ô½¶àµÄÖ¤¾ÝÅú×¢£¬£¬£¬FOXP3²¢²»ÊÜÏÞÓÚÔÚTϸ°ûÖеıí´ï£¬£¬£¬ÆäÔÚ¾ÞÊÉϸ°ûÖÐÒàÓбí´ï¡£²Î¿¼FOXP3µÄ¹Å°å¹¦Ð§Óë×÷Ó㬣¬£¬¸Ã·Ö×Ó¿ÉÄÜÊǵ÷Àí¾ÞÊÉϸ°ûÊôÐÔµÄÒªº¦½ÇÉ«¡£ÓÉ´Ë£¬£¬£¬ÓÐÐëÒªÕö¿ªFOXP3ÔÚ¾ÞÊÉϸ°ûÖеĹ¦Ð§Ñо¿¡£
Ñо¿Í¨¹ý¹¹½¨ËèÏµÌØÒìÐÔFOXP3ÇóýСÊó(Lyz2 Cre-ERT2foxp3 fl/Y)¼°¶ÌÔÝÐÔ´óÄÔÖж¯Âö±ÕÈû(tMCAO)Ä£×ÓÑо¿ÁËFOXP3ÔÚAISÖоÞÊÉϸ°ûµÄ×÷Ó᣸ÃÑо¿±¨µÀÁËÔÚÖзçÄÔ¹£ËÀÖÜÎ§ÇøÓò±£´æFOXP3+¾ÞÊÉϸ°û¡£ÍŶÓͨ¹ýscRNAseqºÍ¶ÔFOXP3-ChIPµÄÆÊÎö£¬£¬£¬·¢Ã÷FOXP3¾ßÓÐÕýÏòµ÷¿Ø¾ÞÊÉϸ°ûÍÌÊɺÍÍÌÊÉÎïÆÊÎö´úлµÄ¹¦Ð§¡£Óë¾ÞÊÉϸ°ûM1»òM2ÑÇȺ²î±ðµÄÊÇ£¬£¬£¬FOXP3+¾ÞÊÉϸ°ûÌåÏÖ³öÔöÇ¿µÄ°ûÔá×÷ÓúͿ¹Ñ×ЧÂÊ¡£
ΪÑо¿ÔÚAISÖÐFOXP3Òò×Óµ÷¿Ø¾ÞÊÉϸ°û¹¦Ð§µÄ»úÖÆ£¬£¬£¬ÍŶÓͨ¹ýÃâÒß¹²³Áµí(IP)ÊèÉ¢³öÔ´ú×÷ÓýµÄ¹ÇËèȪԴµÄ¾ÞÊÉϸ°ûÖеÄFOXP3Á¬ÏµÂѰף¬£¬£¬¾ÙÐÐÁËÒºÏàÉ«Æ×-ÖÊÆ×(LC-MS)ÆÊÎöºÍGO-BPÆÊÎö¡£Ð§¹û·¢Ã÷£¬£¬£¬ÔÚ¾²Ï¢¾ÞÊÉϸ°ûÖУ¬£¬£¬FOXP3¿ÉÎȹ̶øÉÙÁ¿µØ±í´ï£¬£¬£¬µ«»áͨ¹ýLC3Ïà¹ØÍÌÊÉ×÷ÓÃ(LAP)µÄ×ÔÊÉ»úÖÆÒ»Ö±½µ½â¡£Ò»µ©¾ÞÊÉϸ°ûÓöµ½×äÖÐÏà¹Ø´Ì¼¤£¬£¬£¬¾Í»áÆô¶¯LAP£¬£¬£¬¾ºÕùÐÔµØÕ¼ÓÐ×ÔÊÉ»úÖÆ£¬£¬£¬µ¼ÖÂFOXP3´Ó×ÔÊɽµ½âÖÐÊͷųöÀ´£¬£¬£¬²¢×ªÔ˵½Ï¸°ûºËÖУ¬£¬£¬Éϵ÷ÍÌÊɺÍÍÌÊÉÎïÆÊÎö´úлÏà¹Ø»ùÒòµÄת¼¡£ÕâÅú×¢FOXP3ÐźÅÊÇÓÉÒ»¸öÖØ´ó·Ö×ÓÍøÂçÇÉÃϸÄ嵨¾ÙÐпØÖÆ£¬£¬£¬²¢ÇÒ¸ÃÍøÂç¿ÉÒÔ¿ìËÙ΢µ÷¾ÞÊÉϸ°ûÔÚAISÖеĻ¡£

FOXP3ÔÚ¾ÞÊÉϸ°ûÖÐ×÷ÓûúÖÆÊ¾Òâͼ
±¾Ñо¿Ô´´ÐԵزûÎöÁËFOXP3ÔÚAIS¹£ËÀÇøÖÜΧµÄ¾ÞÊÉϸ°ûÖбí´ï£¬£¬£¬²¢¿ÉÕýÏòµ÷Àí¾ÞÊÉϸ°ûµÄÍÌÊɺͿ¹Ñ×¹¦Ð§¡£Ñо¿½øÒ»²½·¢Ã÷ÔÚAISÖУ¬£¬£¬FOXP3ÔÚ¾ÞÊÉϸ°ûÖеĿìËÙ¼¤»îÓëLC3Ïà¹ØÍÌÊÉ×÷ÓÃÏà¹Ø¡£ÓÉ´ËÌá³ö£¬£¬£¬FOXP3ÊÇÒ»¸ö¾ß±¸Ç±ÔÚÑо¿¼ÛÖµµÄ·Ö×Ӱб꣬£¬£¬ÆäÔÚȱѪÄÔ×éÖ¯ÖоßÓÐÔöÇ¿¾ÞÊÉϸ°û°ûÔá×÷Ó㬣¬£¬²¢¿ÉÔö½øÑ×Ö¢ÏûÍË´Ó¶ø¼õÇáÄÔËðÉ˲¢Ôö½ø×äÖлָ´£¬£¬£¬ÎªAISµÄÖÎÁÆÌṩÁËеÄÀíÂÛ»ù´¡ºÍ¸ÉÔ¤Õ½ÂÔ¡£
¸ÃÂÛÎÄͨѶ×÷ÕßΪngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐĽÕýÆë½ÌÊÚ¡¢¡¢ÁÙ´²ÃâÒßѧÖÐÐijÑÒ½ÌÊÚ¼°ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÁõÇ¿½ÌÊÚ¡£µÚÒ»×÷ÕßΪngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐIJÌε¸±Ñо¿Ô±¡¢¡¢Éñ¾ÄڿƲ©Ê¿Ñо¿ÉúºúÃÎÑÕ¡£
ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1080/15548627.2022.2116833